Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitors
Keyword(s):
The evolution of picolinamide derived LRRK2 inhibitors with improved kinase off target selectivity and de-risked for AMES mutagenicity.
2016 ◽
Vol 16
(5)
◽
pp. 400-414
◽
2014 ◽
Vol 3
(1)
◽
pp. 2-6
◽
Keyword(s):